一个工程外细胞囊,增强了瘤和淋巴结的向,作为siRNA输送系统,用于强大的瘤免疫疗法
Yusi Wang1, Rui Zhang1, Xuejing Zhou1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital Sichuan University Chengdu China.
MedComm
|March 12, 2026
概括
携带瘤抗原和向的工程外细胞囊泡 (EVs) 显示出增强的积累和改善的免疫反应. 这种新型的癌症疫苗平台DP-EVs/siPD-L1通过激活抗瘤免疫力和逆转免疫抑制,有效抑制瘤生长.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 来自瘤的细胞外囊泡 (EVs) 显示出作为个性化癌症疫苗的潜力,但缺乏特定的组织向.
- 工程电动汽车可以增强其免疫治疗能力.
研究的目的:
- 在癌症免疫治疗中改进瘤衍生的EV,以提高向和治疗疗效.
- 开发一种新的癌症疫苗平台,将向的EV与免疫检查点封锁相结合.
主要方法:
- 用DP7-C (DP-EVs) 改造瘤EVs,以加强对淋巴结和瘤的向.
- 用小干扰RNA准PD-L1 (siPD-L1) 的装载DP-EVs来创建DP-EVs/siPD-L1.
- 在携带瘤的小鼠体内评估疗效,评估瘤生长,存活,免疫激活和瘤微环境调节.
主要成果:
- DP-EVs在淋巴结和瘤中显示出增强的积累,细胞吸收和内分体逃逸的改善.
- 在树突细胞和瘤细胞中,DP-EVs/siPD-L1有效抑制了PD-L1的表达.
- 在小鼠中,DP-EVs/siPD-L1显著抑制瘤生长和延长存活时间.
- 治疗效应与免疫激活和免疫抑制瘤微环境的重塑有关.
结论:
- 工程电动汽车 (DP-EVs/siPD-L1) 是一个有前途的癌症疫苗平台.
- 这种策略协同激活抗瘤免疫力,并逆转瘤微环境介导的免疫抑制.
- 设计的EV平台为先进的癌症免疫疗法提供了可翻译的方法.
更多相关视频
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K


